[widget-area id='above-title-area']

Glycemic Control in Type 2 Diabetics

[widget-area id='below-title-area']
[widget-area id='above-article-area']
[widget-area id='in-article-area']


Valeritas, Inc., a company focused on the development of technologies for patients with type 2 diabetes, has released positive results of a new evaluation of its insulin delivery device, the V-Go®. The article documenting the analysis is entitled “Use of V-Go® Insulin Delivery Device in Patients with Sub-optimally Controlled Diabetes Mellitus: A Retrospective Analysis from a Large Specialized Diabetes System” and was recently published in the journal Diabetes Therapy.


Learn more about it: http://bit.ly/1OkCpVY

[widget-area id='below-article-area']

Leave a Comment